Search Results - "PIGOTT, Teresa A"

Perspective: the evolution of hormones and person perception-a quantitative genetic framework by Gurguis, Christopher I, Kimm, Tyler S, Pigott, Teresa A

“…Evolutionary biology provides a unifying theory for testing hypotheses about the relationship between hormones and person perception. Person perception usually…”
Get full text

Higher Prevalence of Metabolic Syndrome in Child-adolescent Patients with Bipolar Disorder by Mohite, Satyajit, Wu, Hanjing, Sharma, Shiva, Lavagnino, Luca, Zeni, Cristian P, Currie, Terrence T, Soares, Jair C, Pigott, Teresa A

“…Previous studies have indicated a convergent and bidirectional relationship between metabolic syndrome (MetS) and bipolar disorder (BD). As most of these…”
Get full text

Anxiety disorders in women by Pigott, Teresa A

“…Women have higher overall prevalence rates for anxiety disorders than men. Women are also much more likely than men to meet lifetime criteria for each of the…”
Get more information

Race, History of Abuse, and Homelessness Are Associated With Forced Medication Administration During Psychiatric Inpatient Care by THOMAS, TINA E., LANE, SCOTT D., ELKHATIB, RANIA M., HAMILTON, JANE E., PIGOTT, TERESA A.

“…Objective: Although previous research has suggested that racial disparities exist in the administration of forced medication (FM) in psychiatric inpatients,…”
Get full text

Aripiprazole for the prevention of relapse in stabilized patients with chronic schizophrenia: A placebo-controlled 26-week study by PIGOTT, Teresa A, CARSON, William H, SAHA, Anutosh R, TORBEYNS, Anne F, STOCK, Elyse G, INGENITO, Gary G

“…Aripiprazole is a novel antipsychotic for the management of schizophrenia. This study investigated the efficacy, safety, and tolerability of aripiprazole in…”
Get full text

An Unusual Case of Acute Psychosis With Obsessive-Compulsive Features Following Arsenic Poisoning by Wu, Hanjing E, Abdel-Gawad, Noha M, Gharbaoui, Yasmine, Teixeira, Antonio L, Pigott, Teresa A

“…Arsenic exposure, particularly the chronic type, can lead to poisoning with manifestations presenting in multiple organ systems. However, acute psychosis is…”
Get full text

Atomoxetine Treatment of Attention-Deficit/Hyperactivity Disorder in Young Adults With Assessment of Functional Outcomes: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial by DURELL, Todd M, ADLER, Lenard A, WILLIAMS, Dave W, DELDAR, Ahmed, MCGOUGH, James J, GLASER, Paul E, RUBIN, Richard L, PIGOTT, Teresa A, SARKIS, Elias H, FOX, Bethany K

“…Attention-deficit/hyperactivity disorder (ADHD) is associated with significant impairment in multiple functional domains. This trial evaluated efficacy in ADHD…”
Get full text

Gender differences in the epidemiology and treatment of anxiety disorders by Pigott, T A

“…Women are more likely than men to develop anxiety disorders. Yet, relatively few studies have investigated whether women with anxiety disorders have…”
Get full text

Early-Life Trauma in Hospitalized Patients With Mood Disorders and Its Association With Clinical Outcomes by Parsaik, Ajay K, Abdelgawad, Noha, Chotalia, Jigar K, Lane, Scott D, Pigott, Teresa A

“…The prevalence of childhood trauma and its impact on clinical outcomes in hospitalized patients with mood disorders is unknown. We studied the frequency of…”
Get full text

A review of the efficacy of selective serotonin reuptake inhibitors in obsessive-compulsive disorder by PIGOTT, T. A, SEAY, S. M

“…Obsessive-compulsive disorder (OCD) is a chronic illness associated with substantial morbidity; it often requires long-term medication. The best-studied…”
Get full text

Duloxetine versus escitalopram and placebo: an 8-month, double-blind trial in patients with major depressive disorder by Pigott, Teresa A., Prakash, Apurva, Arnold, Lesley M., Aaronson, Scott T., Mallinckrodt, Craig H., Wohlreich, Madelaine M.

“…ABSTRACT Background: Duloxetine and escitalopram were compared in an 8-month, randomized, double-blind, placebo-controlled trial in adult outpatients meeting…”
Get full text

The Texas medication Algorithm project : Report of the Texas consensus conference panel on medication treatment of major depressive disorder by CRISMON, M. L, TRIVEDI, M, THASE, M. E, PIGOTT, T. A, RUSH, A. J, HIRSCHFELD, R. M. A, KAHN, D. A, DEBATTISTA, C, NELSON, J. C, NIERENBERG, A. A, SACKEIM, H. A

“…This article describes the development of consensus medication algorithms for the treatment of patients with major depressive disorder in the Texas public…”
Get full text

Effectiveness of low doses of paroxetine controlled release in the treatment of major depressive disorder by TRIVEDI, Madhukar H, PIGOTT, Teresa A, PERERA, Philip, DILLINGHAM, Kerry E, CARFAGNO, Michelle L, PITTS, Cornelius D

“…Paroxetine controlled release (CR) is approved for the treatment of major depressive disorder (MDD) in the dosage range of 25 to 62.5 mg daily. However, lower…”
Get full text

Pharmacotherapy of obsessive-compulsive disorder by A. PIGOTT, TERESA, SEAY, SHEILA

“…Obsessive-compulsive disorder (OCD) is a chronic and often incapacitating disorder that is frequently complicated by mood and additional anxiety diagnoses…”
Get full text

OCD : Where the serotonin selectivity story begins by PIGOTT, T. A

“…Since concomitant anxiety is frequent and prominent, obsessive-compulsive disorder (OCD) is classified as an anxiety disorder. However, effective…”
Get full text

Double-blind study of adjuvant buspirone for fluoxetine-treated patients with obsessive-compulsive disorder by Grady, T A, Pigott, T A, L'Heureux, F, Hill, J L, Bernstein, S E, Murphy, D L

“…In a double-blind, crossover study, 13 fluoxetine-treated patients with obsessive-compulsive disorder were given adjuvant buspirone and placebo for 4 weeks…”
Get more information

Acute intravenous administration of ondansetron and m-CPP, alone and in combination, in patients with obsessive–compulsive disorder (OCD): behavioral and biological results by Broocks, Andreas, Pigott, Teresa A, Hill, James L, Stephanie Canter, Grady, Tana A, L'Heureux, Francine, Murphy, Dennis L

“…Obsessive–compulsive disorder (OCD) has been linked to abnormal function of brain serotonin (5-HT) pathways. Since ondansetron is a highly selective 5-HT 3…”
Get full text

Memory in sub-clinical obsessive-compulsive checkers by Rubenstein, C S, Peynircioglu, Z F, Chambless, D L, Pigott, T A

“…In a series of experiments we extended the research on possible memory deficits in subclinical obsessive-compulsive Ss who reported excessive checking. Using a…”
Get more information

Obsessive-compulsive disorder: symptom overview and epidemiology by Pigott, T A

“…Obsessive-compulsive disorder (OCD) is associated with substantial psychosocial impairment. Although large-scale population surveys suggest that OCD is fairly…”
Get more information

Behavioral, physiological and neuroendocrine responses in healthy volunteers to m-chlorophenylpiperazine (m-CPP) with and without ondansetron pretreatment by BROOCKS, A, BRIGGS, N. C, PIGOTT, T. A, HILL, J. L, CANTER, S. K, TOLLIVER, T. J, BALDEMORE, D, MURPHY, D. L

“…Several serotonin3 (5-HT3) antagonists have been shown to attenuate the anxiogenic effects of the serotonergic agent, m-chlorophenylpiperazine (m-CPP), in…”
Get full text